These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27553068)

  • 1. Herpes zoster laryngitis in a patient treated with fingolimod.
    Hagiya H; Yoshida H; Shimizu M; Motooka D; Nakamura S; Iida T; Yamamoto N; Akeda Y; Tomono K
    J Infect Chemother; 2016 Dec; 22(12):830-832. PubMed ID: 27553068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.
    Harrer A; Wipfler P; Pilz G; Oppermann K; Haschke-Becher E; Afazel S; Kraus J; Trinka E; Sellner J
    Int J Mol Sci; 2015 Sep; 16(9):21832-45. PubMed ID: 26378517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequency of varicella-zoster virus infection in patients with multiple sclerosis receiving fingolimod.
    Aramideh Khouy R; Karampoor S; Keyvani H; Bokharaei-Salim F; Monavari SH; Taghinezhad S; Etemadifar M; Esghaei M
    J Neuroimmunol; 2019 Mar; 328():94-97. PubMed ID: 30610966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The risk of varicella zoster virus infection in multiple sclerosis patients treated with fingolimod].
    Tanaka M
    Rinsho Shinkeigaku; 2016 Apr; 56(4):270-2. PubMed ID: 27010095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management.
    Arvin AM; Wolinsky JS; Kappos L; Morris MI; Reder AT; Tornatore C; Gershon A; Gershon M; Levin MJ; Bezuidenhoudt M; Putzki N
    JAMA Neurol; 2015 Jan; 72(1):31-9. PubMed ID: 25419615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Odynophagia in patient with varicella zoster reactivation].
    Reiter R; Hoffmann TK; Brosch S; Pickhardt A; Reichert M
    Laryngorhinootologie; 2014 Oct; 93(10):684-5. PubMed ID: 25302596
    [No Abstract]   [Full Text] [Related]  

  • 7. T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
    Ricklin ME; Lorscheider J; Waschbisch A; Paroz C; Mehta SK; Pierson DL; Kuhle J; Fischer-Barnicol B; Sprenger T; Lindberg RL; Kappos L; Derfuss T
    Neurology; 2013 Jul; 81(2):174-81. PubMed ID: 23700335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis.
    Tagawa A; Ogawa T; Tetsuka S; Otsuka M; Hashimoto R; Kato H; Ando K; Tanabe H
    Mult Scler Relat Disord; 2016 Sep; 9():155-7. PubMed ID: 27645365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Kanda Y; Mineishi S; Saito T; Saito A; Yamada S; Ohnishi M; Chizuka A; Niiya H; Suenaga K; Nakai K; Takeuchi T; Makimoto A; Tanosaki R; Kami M; Tanaka Y; Fujita S; Watanabe T; Kobayashi Y; Tobinai K; Takaue Y
    Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes zoster: a potential risk associated with fingolimod treatment.
    Mayor Ibarguren A; Gómez Fernández C; Tallón Barranco A; Fernández Fournier M; González Ramos J; Romero Gómez MP; Herranz Pinto P
    Int J Dermatol; 2015 Sep; 54(9):e373-5. PubMed ID: 26173466
    [No Abstract]   [Full Text] [Related]  

  • 11. Laryngeal herpes: a case report.
    Pinto JA; Pinto HC; Ramalho Jda R
    J Voice; 2002 Dec; 16(4):560-3. PubMed ID: 12512643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-shift in varicella-zoster virus-specific T-cell immunity over the course of Fingolimod-treatment in relapse-remitting multiple sclerosis patients.
    Matko S; Akgün K; Tonn T; Ziemssen T; Odendahl M
    Mult Scler Relat Disord; 2020 Feb; 38():101859. PubMed ID: 31855843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case series.
    Signoriello E; Bonavita S; Sinisi L; Russo CV; Maniscalco GT; Casertano S; Saccà F; Lanzillo R; Morra VB; Lus G
    Mult Scler Relat Disord; 2020 May; 40():101963. PubMed ID: 31986424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcal meningitis in a multiple sclerosis patient treated with Fingolimod: a case report and review of imaging findings.
    Chong I; Wang KY; Lincoln CM
    Clin Imaging; 2019; 54():53-56. PubMed ID: 30544079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
    Kohlmann R; Salmen A; Chan A; Knabbe C; Diekmann J; Brockmeyer N; Skaletz-Rorowski A; Michalik C; Gold R; Überla K
    Mult Scler; 2015 Dec; 21(14):1823-32. PubMed ID: 25828755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Presentation of a Common Disease: Shingles of the Larynx.
    Hosseini S; Zawawi F; Young J
    J Voice; 2015 Sep; 29(5):600-2. PubMed ID: 25873549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Asano-Mori Y; Kanda Y; Oshima K; Kako S; Shinohara A; Nakasone H; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2008 Jun; 83(6):472-6. PubMed ID: 18266207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polydermatomal perineal and gluteal herpes zoster infection in a patient on fingolimod treatment.
    Kawiorski MM; Viedma-Guiard E; Costa-Frossard L; Corral I
    Enferm Infecc Microbiol Clin; 2015 Feb; 33(2):138-9. PubMed ID: 24958672
    [No Abstract]   [Full Text] [Related]  

  • 19. Herpes zoster laryngitis: case report and serological profile.
    Watelet JB; Evrard AS; Lawson G; Bonte K; Remacle M; Van Cauwenberge P; Vermeersch H
    Eur Arch Otorhinolaryngol; 2007 May; 264(5):505-7. PubMed ID: 17124598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
    Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.